Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that the company will present seven abstracts, including two oral sessions, at the American Association for ...
As the Trump administration phases out the use of animal experimentation across the federal government, a biotech startup has a bold idea for an alternative to animal testing: nonsentient “organ sacks ...
“Why her?” the journalist Mark Oppenheimer writes toward the end of his first biography, “Judy Blume: A Life.” “What is it about Judy and her work that won her so many millions of fans?” Partly talent ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results